Lilly says antibody drug cuts COVID-19 hospitalization, may seek emergency use nod

Of the total 302 patients treated with the Lilly drug, five or 1.7%,
had to be hospitalized or required an emergency room visit. That
compared with 6% in the placebo group, Lilly said.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/antibody-made-by-eli-lilly-helping-in-covid-treatment/articleshow/78154453.cms